NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
CC E-040-1997-0-US-03 Method For Segmenting Medical Images and Detecting Surface Anomolies in Anatomical Structures US DIV 09/765,826 6345112 Expired PDF
CC E-229-1999-0-PCT-02 Vessel Delineation in Magnetic Resonance Angiographic Images PCT PCT PCT/US01/01851 Expired
NIDDK E-104-1997-0-PCT-04 USE OF PENTOSAN POLYSULFATE TO TREAT CERTAIN CONDITIONS OF THE PROSTATE PCT PCT PCT/US01/01837 Expired
NIDDK E-104-1997-0-AR-09 REDUCTION OF PROLIFERATION AND SCARRING BY PROSTATE AR ORD 20010100243 Abandoned
CC E-229-1999-0-EP-03 Vessel Delineation in Magnetic Resonance Angiographic Images EP National Stage 01951183.1 Abandoned
NIDDK E-104-1997-0-US-02 USE OF PENTOSAN POLYSULFATE TO TREAT CERTAIN CONDITIONS OF THE PROSTATE US ORD 09/766,245 Abandoned
NIDDK E-104-1997-0-CL-10 REDUCTION OF PROLIFERATION AND SCARRING BY PROSTATE CL ORD 135-2001 Abandoned
NIDDK E-104-1997-0-CO-06 REDUCTION OF PROLIFERATION AND SCARRING BY PROSTATE CO National Stage 01003921 Abandoned
NIDDK E-104-1997-0-TW-05 REDUCTION OF PROLIFERATION AND SCARRING BY PROSTATE TW ORD 90101354 Abandoned
NCI E-035-1994-2-US-05 Isolation Of Cellular Material Under Microscopic Visualization US CON 09/765,937 6569639 Abandoned PDF
NHGRI E-162-2001-0-PCT-02 Oligonucleotide-Tagged Semiconductor Nanocyrstrals for Microarray And Fluorescence In Situ Hybridization PCT PCT PCT/US01/02001 Abandoned
NIA E-021-2000-0-PCT-02 Method and Apparatus for Coating an Endoprosthesis PCT PCT PCT/US01/001783 Expired
NHGRI E-162-2001-0-US-01 Oligonucleotide-Tagged Semiconductor Nanocyrstrals for Microarray And Fluorescence In Situ Hybridization US ORD 09/766,273 Abandoned
NIDCR E-003-1999-0-CA-05 Nucleic Acids Encoding a G-protein Coupled Receptor Involved in Sensory Transduction CA National Stage 2335318 Expired
NCI E-025-1998-0-AU-03 FUSED AZEPINONE CYCLIN DEPENDENT KINASE INHIBITORS AU National Stage 15009/01 Abandoned
NCI E-065-1996-2-US-25 ACRIDONE-DERIVED COMPOUNDS USEFUL AS ANTINEOPLASTIC AND ANTIRETROVIRAL AGENTS US DIV 09/760,047 6541483 Abandoned PDF
NIDDK E-176-1999-0-CA-04 Methanocarba Cycloalkyl Nucleoside Analogues CA National Stage 2397366 Expired
NIDDK E-176-1999-0-GB-08 METHANYLCARBA CYCLOALKYL NUCLEOSIDE ANALOGUES GB EP 01903043.6 Expired
NIDDK E-176-1999-0-EP-05 Methanocarba Cycloalkyl Nucleoside Analogues EP National Stage 01903043.6 Abandoned
NIDDK E-176-1999-0-AU-03 Methanocarba Cycloalkyl Nucleoside Analogues AU National Stage 2001230913 Expired
NIDDK E-176-1999-0-PCT-02 Methanylcarba Cycloalkyl Nucleoside Analogues PCT PCT PCT/US01/00981 Expired
NIMH E-038-2001-0-US-01 Decoding Algorithm For Neuronal Responses US 60/261,494 Abandoned
NCI E-201-1998-0-US-06 Recombinant Immunotoxin Directed Against the HIV-1 GP120 Envelope Glycoprotein US National Stage 09/673,707 Abandoned
NCI E-060-2000-0-US-01 sFRP and Peptide Motifs that Interact with sFRP and Methods of Their Use (as Filed) US 60/260,908 Abandoned
NCI E-286-2000-0-US-01 Histone Deacetylase Inhibitors in Diagnosis and Treatment of Thyroid Neoplasms US 60/260,733 Abandoned
NCI E-268-1997-3-US-01 Mucosal Cytotoxic T Lymphocyte Responses US 60/261,083 Abandoned
NCI E-251-2000-1-US-01 Telomerase Immortalized Fibroblast Cell Lines US 60/260,625 Abandoned
NCI E-157-1993-2-US-03 New Procedure To Block The Replication of Reverse Transcriptase Dependent Viruses By The Use of Inhibitors of Deoxynucleotide Synthesis US CON 09/756,411 Abandoned
NCI E-018-2002-0-US-01 Application of Spliceosome-Mediated RNA Trans-Splicing (SMART tm) Gene Therapy To The Treatment of Human Papillimavirus... US 60/260,478 Abandoned
NIDDK E-111-1996-1-US-03 Compounds for Cancer Imaging and Therapy US DIV 09/755,366 6517811 Abandoned PDF
NIAID E-015-1998-0-US-10 Multivalent Human-Bovine Rotavirus Vaccine US National Stage 09/743,338 7932074 Expired PDF
NCI E-079-1999-2-US-01 Method And Kits For Proteomic Analysis Idenfification US CIP 09/753,574 Abandoned
NCI E-068-2000-0-PCT-02 Molecules That Influence Pathogen Resistance PCT PCT PCT/US01/00059 Expired
NCI E-068-2000-0-EP-03 Molecules That Influence Pathogen Resistance EP National Stage 01901664.1 Abandoned
NHGRI E-163-2001-0-US-03 Myocardial Regeneration By Injection Of Hemaotopoietic Stem Cells US 60/258,805 Abandoned
NHGRI E-211-1998-0-US-03 Methods for Detecting Cancer Cells US National Stage 09/937,864 Abandoned
NICHD E-013-2000-0-CA-04 Process For Preparing 17a-Acetoxy-11b-[4-N,N-(Dimethylamino)Phenyl]-21-Methoxy-19-Norpregna-4,9-Diene-3,20-Dione, Intermediates Useful in the Process, and Processes for Preparing Such Intermediates CA National Stage 2394731 Abandoned
NICHD E-013-2000-0-CH-09 Improved Process Development of 17alpha-acetoxy-11beta-(4-(N,N- dimethylamino)phenly)-21-Methoxy-19-norpregna-4,9-diene-3,20-dione CH EP 00989551.7 Abandoned
NICHD E-013-2000-0-GB-12 Improved Process Development of 17alpha-acetoxy-11beta-(4-(N,N- dimethylamino)phenly)-21-Methoxy-19-norpregna-4,9-diene-3,20-dione GB EP 00989551.7 Abandoned
NICHD E-013-2000-0-IT-13 Improved Process Development of 17alpha-acetoxy-11beta-(4-(N,N- dimethylamino)phenly)-21-Methoxy-19-norpregna-4,9-diene-3,20-dione IT EP 00989551.7 Abandoned
NICHD E-013-2000-0-AT-07 Improved Process Development of 17alpha-acetoxy-11beta-(4-(N,N- dimethylamino)phenly)-21-Methoxy-19-norpregna-4,9-diene-3,20-dione AT EP 00989551.7 Abandoned
NICHD E-013-2000-0-BE-08 Improved Process Development of 17alpha-acetoxy-11beta-(4-(N,N- dimethylamino)phenly)-21-Methoxy-19-norpregna-4,9-diene-3,20-dione BE EP 00989551.7 Abandoned
NICHD E-013-2000-0-DE-10 Improved Process Development of 17alpha-acetoxy-11beta-(4-(N,N- dimethylamino)phenly)-21-Methoxy-19-norpregna-4,9-diene-3,20-dione DE EP 00989551.7 Abandoned
NICHD E-013-2000-0-FR-11 Improved Process Development of 17alpha-acetoxy-11beta-(4-(N,N- dimethylamino)phenly)-21-Methoxy-19-norpregna-4,9-diene-3,20-dione FR EP 00989551.7 Abandoned
NICHD E-013-2000-0-LU-14 Improved Process Development of 17alpha-acetoxy-11beta-(4-(N,N- dimethylamino)phenly)-21-Methoxy-19-norpregna-4,9-diene-3,20-dione LU EP 00989551.7 Abandoned
NICHD E-013-2000-0-EP-05 Improved Process Development of 17alpha-acetoxy-11beta-(4-(N,N- dimethylamino)phenyl)-21-Methoxy-19-norpregna-4,9-diene-3,20-dione EP National Stage 00989551.7 Abandoned
NICHD E-013-2000-0-AU-03 Improved Process Development of 17alpha-acetoxy-11beta-(4-(N,N- dimethylamino)phenly)-21-Methoxy-19-norpregna-4,9-diene-3,20-dione AU National Stage 2001026048 Abandoned
NICHD E-013-2000-0-PCT-02 Improved Process Development of 17alpha-acetoxy-11beta-(4-(N,N- dimethylamino)phenly)-21-Methoxy-19-norpregna-4,9-diene-3,20-dione PCT PCT PCT/US2000/035479 Expired
NHGRI E-163-2001-0-US-02 STEM CELL MOBILIZATION LEADS TO REGENERATION OF INFARCTED MYOCARDIUM AMELIORATING CENTRICULAR PERFORMANCE IN MICE. US 60/258,564 Abandoned
NCI E-062-2000-1-US-01 Novel Human Septin And Uses Therefor US 60/258,725 Abandoned